Wolters Kluwer Clinical Drug Solutions Trusted by 25 of the 27 2015-2016 Honor Roll Hospitals Ranked by U.S. News & World Report

Date: 
Friday, August 28, 2015

August 28, 2015 – The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, announced today that its Clinical Drug Information solutions are used in 25 out of the 27 top-scoring hospitals achieving Honor Roll status in U.S. News & World Report Best Hospitals and Best Children’s Hospitals 2015-2016 rankings. Additionally, its Lexicomp® drug references are used by 19 of the 20 top-ranked pediatric hospitals for neonatology from the U.S. News & World Report 2015-2016 Best Children’s Hospitals list.

The 2015-16 hospital rankings evaluated surveys of more than 140,000 physicians across nearly 5,000 medical centers in the U.S. High scores within at least six of the 16 specialties evaluated earned 15 hospitals a place on the Honor Roll. Death rates, patient safety and hospital reputation were a few of the many factors considered. In the category of best children's hospitals, evaluations were conducted across 10 specialties, and high scores in three or more of the 10 specialties examined earned Honor Roll status for 12 hospitals.

Wolters Kluwer’s Clinical Drug Information unites the expertise of more than 300 professionals to provide aligned drug information resources across its leading applications, Lexicomp, Medi-Span® and Facts & Comparisons®. Thousands of hospitals in the U.S. use clear, concise Lexicomp and Facts & Comparisons drug references online, on mobile apps, and integrated into EMR functions to provide clinically relevant drug content and interactive clinical tools at the point of care. Hospitals trust Medi-Span drug data, integrated in their EMRs, to power medication safety screenings and meaningful clinical alerts. Together, these aligned solutions help health systems reduce medication errors, enhance patient safety, lower system-wide costs, and increase workflow efficiency throughout the continuum of care.

“Once again, Wolters Kluwer is proud to be the trusted drug information provider to so many of the nation’s top hospitals, according to the prestigious U.S. News & World Report rankings,” said Denise Basow, MD, President & CEO of Clinical Effectiveness at Wolters Kluwer. “The strong, ongoing relationships between Clinical Drug Information and these respected, high-performing healthcare institutions serve as a testament to our commitment to quality and innovation and to the hospitals’ dedication to superior patient care.”

About Wolters Kluwer

Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit www.wolterskluwerhealth.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

Media
Meagan McCord
Manager, Marketing Communications
Wolters Kluwer | Clinical Solutions
330-650-6506
meagan.mccord@wolterskluwer.com